Uniphar (UPR) Competitors GBX 353 +7.00 (+2.02%) As of 03:37 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock UPR vs. UDG, MDC, BTG, ABC, HCM, ONT, INDV, GNS, CLIN, and EMISShould you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), Mediclinic International (MDC), BTG (BTG), Abcam (ABC), HUTCHMED (HCM), Oxford Nanopore Technologies (ONT), Indivior (INDV), Genus (GNS), Clinigen Group (CLIN), and EMIS Group (EMIS). These companies are all part of the "medical" sector. Uniphar vs. Its Competitors UDG Healthcare Mediclinic International BTG Abcam HUTCHMED Oxford Nanopore Technologies Indivior Genus Clinigen Group EMIS Group Uniphar (LON:UPR) and UDG Healthcare (LON:UDG) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership. Is UPR or UDG a better dividend stock? Uniphar pays an annual dividend of GBX 2 per share and has a dividend yield of 0.6%. UDG Healthcare pays an annual dividend of GBX 0.17 per share. Uniphar pays out 13.9% of its earnings in the form of a dividend. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Does the media refer more to UPR or UDG? In the previous week, Uniphar had 1 more articles in the media than UDG Healthcare. MarketBeat recorded 1 mentions for Uniphar and 0 mentions for UDG Healthcare. Uniphar's average media sentiment score of 0.24 beat UDG Healthcare's score of 0.00 indicating that Uniphar is being referred to more favorably in the media. Company Overall Sentiment Uniphar Neutral UDG Healthcare Neutral Which has stronger valuation and earnings, UPR or UDG? Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniphar£3.03B0.36£51.04M£14.3824.55UDG Healthcare£1.25B0.00N/A£25.40N/A Do institutionals and insiders hold more shares of UPR or UDG? 45.3% of Uniphar shares are owned by institutional investors. 10.1% of Uniphar shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer UPR or UDG? Uniphar currently has a consensus price target of GBX 375, indicating a potential upside of 6.23%. Given Uniphar's stronger consensus rating and higher possible upside, analysts clearly believe Uniphar is more favorable than UDG Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Uniphar 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50UDG Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is UPR or UDG more profitable? Uniphar has a net margin of 1.68% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.18% beat UDG Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Uniphar1.68% 13.18% 3.76% UDG Healthcare N/A N/A N/A SummaryUniphar beats UDG Healthcare on 12 of the 15 factors compared between the two stocks. Get Uniphar News Delivered to You Automatically Sign up to receive the latest news and ratings for UPR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPR vs. The Competition Export to ExcelMetricUnipharMedical Distribution IndustryMedical SectorLON ExchangeMarket Cap£1.10B£1.10B£5.78B£3.17BDividend Yield0.77%1.33%3.95%5.04%P/E Ratio24.556.0731.27170.02Price / Sales0.3636.21429.14474,878.67Price / Cash9.979.9737.7327.93Price / Book2.772.7710.196.50Net Income£51.04M£51.04M£3.27B£5.89B7 Day Performance4.28%0.31%1.37%0.34%1 Month Performance4.68%0.48%6.17%50.12%1 Year Performance53.21%5.55%43.98%144.70% Uniphar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPRUniphar0.9832 of 5 starsGBX 353+2.0%GBX 375+6.2%+51.8%£1.10B£3.03B24.553,000News CoverageHigh Trading VolumeUDGUDG HealthcareN/AN/AN/AN/A£2.72B£1.25B42.489,000MDCMediclinic InternationalN/AN/AN/AN/A£3.69B£3.38B2,178.261,640BTGBTGN/AN/AN/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeHCMHUTCHMEDN/AGBX 238.69-1.0%N/A-16.9%£2.59B£771.01M-60.921,760News CoverageONTOxford Nanopore Technologies1.038 of 5 starsGBX 211.40+0.9%GBX 232.50+10.0%+59.4%£2.01B£184.78M-11.381,281INDVIndivior2.4139 of 5 starsGBX 1,238+1.6%GBX 1,650+33.3%+31.7%£1.93B£1.40B-1,026.481,000Gap UpHigh Trading VolumeGNSGenus0.5067 of 5 starsGBX 2,635-0.8%GBX 2,650+0.6%+47.0%£1.73B£666.67M218.42480CLINClinigen GroupN/AN/AN/AN/A£1.23B£565.60M64.691,000EMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560 Related Companies and Tools Related Companies UDG Alternatives MDC Alternatives BTG Alternatives ABC Alternatives HCM Alternatives ONT Alternatives INDV Alternatives GNS Alternatives CLIN Alternatives EMIS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:UPR) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uniphar plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Uniphar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access